Literature DB >> 21844475

Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.

Adam Lerner, Angela Beckford, Steve Ugent, Lynne Goldberg, Scharukh Jalisi, Marie-France Demierre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21844475     DOI： 10.1001/archdermatol.2011.210

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

Review 1.  Current Treatment Options for Cutaneous Adnexal Malignancies.

Authors:  Hiroyuki Goto
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

2.  Malignant acrospiroma: a case report in the era of next generation sequencing.

Authors:  Maria Diab; Ali Gabali; Muaiad Kittaneh
Journal:  BMC Cancer       Date:  2017-03-27       Impact factor: 4.430

3.  Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma.

Authors:  Kristian Larson; Hani M Babiker; Andrew Kovoor; Joy Liau; Jordan Eldersveld; Emad Elquza
Journal:  Case Rep Oncol Med       Date:  2018-03-01

4.  Poroid hidradenocarcinoma and atypical hidradenoma papilliferum of the vulva - Two cases.

Authors:  Monica F G McGauran; Tom Manolitsas; Bassam Tawfik; Dhaval Joshi; Julie M Lamont
Journal:  Gynecol Oncol Rep       Date:  2021-10-25

5.  Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature.

Authors:  Eva Gupta; Kimberly J Guthrie; Murli Krishna; Yan Asmann; Alexander S Parker; Richard W Joseph
Journal:  Rare Tumors       Date:  2015-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.